期刊文献+

门静脉不同部位分流治疗肝肺综合征术后近、中期血气变化 被引量:2

The short-to-mid-term blood gas changes after TIPS with the shunting established at different sites of portal vein for the treatment of hepatopulmonary syndrome
下载PDF
导出
摘要 目的探讨采用门静脉不同部位分流治疗门静脉高压合并肝肺综合征(HPS)患者的近、中期血气变化的临床意义。方法2008年7月-2013年5月对诊断明确的HPS患者行经颈静脉肝内门体分流术(TIPS),对其中81例资料完整的患者进行回顾性分析。81例中,行门静脉主干分流30例(A组),左支分流24例(B组),右支分流27例(C组)。术后常规随访3~12个月,比较门静脉不同部位分流前后平卧不吸氧状态肺泡动脉氧分压差(A—aPO2)、动脉血氧分压(PaO:)和氧饱和度(S02)。结果随访半个月时,A组和B组A—aPO2、PaO2和SO2明显改善,与术前相比差异均有统计学意义(P〈0.05),C组则差异无统计学意义(P〉0.05)。随访3个月时,A组和B组的A—aPO2、PaO2和SO2仍较术前改善,差异有统计学意义(P〈0.05),C组仅A—aPO2较术前差异有统计学意义(P〈0.05)。随访12个月时,B组A—aPO2、PaO2和SO2仍较术前差异有统计学意义(P〈0.05),A组和C组则差异无统计学意义(P〉0.05)。结论采用经门静脉主干或左支TIPS分流可以改善HPS的低氧症状,提高动脉血氧分压.对HPS的近、中期疗效明显.左支分流效果更佳. Objective To discuss the short- to- mid- term blood gas changes in patients with hepatopulmonary syndrome (HPS) after receiving TIPS with the shunting established at different sites of portal vein. Methods During the period from July 2008 to May 2013, transjugular intrahepatic portosystemic shunting (TIPS) was employed in treating clinically-proved HPS at the hospital. A total of 81 cases had complete material, and their clinical data were retrospectively analyzed. Of the 81 cases, shunting was established at the main branch of portal vein in 30 (group A), at the left branch of portal vein in 24 (Group B) and at the fight branch of portal vein in 27 (Group C). After TIPS all the patients were followed up for 3- 12 months. With the patients laying in horizontal position and receiving no oxygen inhalation, A-aPO2, PaO2 and SO2 levels were determined both before and after TIPS. The results were analyzed and compared between each other among the three groups by using paired t-test. Results Half months after TIPS, A-aPO2, PaO2 and SO2 levels of group A and group B showed a significant improvement when compared with those determined before TIPS (P 〈 0.05), while no significant differences in A-aPO2, PaO2 and SOs levels werefound in group C after TIPS (P 〉 0.05). Three months after TIPS, A- aPO:, PaO2 and SO2 levels of group A and group B still showed an obvious improvement when compared with those determined before TIPS (P 〈 0.05), while in group C only the A- aPO2 level showed a significant improvement whencompared with that determined before TIPS (P 〈 0.05). Twelve months after TIPS, A-aPO2, PaO2 and S()2 levels of group B still showed a significant improvement when compared with those determined before TIPS (P 〈 0.05), while those of group A and group C showed no significant changes when compared with those determined before TIPS (P 〉 0.05). Conclusion In performing TIPS for the treatment of hepatopulmonary syndrome, to establish the shunting at the main branch of portal vein or at the left branch of portal vein can effectively relieve the symptoms of hypoxia, increase the PO2 level, and improve the short- to- mid- term efficacy.
出处 《介入放射学杂志》 CSCD 北大核心 2014年第1期26-30,共5页 Journal of Interventional Radiology
基金 2010年北京市科技计划项目“首都特色临床医学应用发展”基金资助项目(Z101107050210023) 首都医科大学附属北京世纪坛医院院级课题基金(2011-C18)
关键词 肝肺综合征 肝硬化 经颈静脉肝内门体分流术 介入放射学 血气分析 hepatopulmonary syndrome cirrhosis transjugular intrahepatic portosystemic shunting interventional radiology blood gas analysis
  • 相关文献

参考文献4

二级参考文献59

  • 1[1]Casado M,Bosch J,Garcia-Pagan JC,Bru C,Banares R,Bandi JC,Escorsell A,Rodriguez-Laiz JM,Gilabert R,Feu F,Schorlemer C,Echenagusia A,Rodes J.Clinical events after transjugular intrahepatic portosystemic shunt:correlation with hemodynamic findings.Gastroenterology 1998; 114:1296-1303
  • 2[2]Riegler JL,Lang KA,Johnson SP,Westerman JH.Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome.Gastroenterology 1995; 109:978-983
  • 3[3]Lasch HM,Fried MW,Zacks SL,Odell P,Johnson MW,Gerber DA,Sandhu FS,Fair JH,Shrestha R.Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome.Liver Transpl 2001; 7:147-149
  • 4[4]Selim KM,Akriviadis EA,Zuckerman E,Chen D,Reynolds TB.Transjugular intrahepatic portosystemic shunt:a successful treatment for hepatopulmonary syndrome.Am J Gastroenterol 1998; 93:455-458
  • 5[5]Allgaier HP,Haag K,Ochs A,Hausentein KH,Jeserich M,Krause T,Heilmann C,Gerok W,Rossle M.Hepatopulmonary syndrome:succesful treatment by transjugular intrahepatic portosystemic shunt (TIPS) (letter).J Hepatoly 1995; 23:102-105
  • 6[6]Corley DA,Scharschmidt B,Bass N,Somberg K,Gold W.Lack of efficacy of TIPS for hepatopulmonary syndrome Gastroenterology 1997; 113:728-730
  • 7[7]Paramesh AS,Husain SZ,Shneider B,Guller J,Tokat I,Gondolesi GE,Moyer S,Emre S.Improvement of hepatopulmonary syndrome after transjugular portosystemic shunting:case report and review of literature.Pediatric transplant 2003;7:157-162
  • 8[8]Rodriguez-Roisin R,Krowka MJ,Herve P,Fallon MB.Pulmonary-Hepatic vascular Disorders (PHD).Eur Respir J 2004; 24:861-880
  • 9[9]Fallon MB,Abrams GA.Pulmonary dysfunction in chronic liver disease.Hepatology 2000; 32:859-865
  • 10[10]Martínez GP,Barbera JA,Visa J,Rimola A,Pare JC,Roca J,Navasa M,Rodes J,Rodriguez-Roisin R.Hepatopulmonary syndrome in candidates for liver transplantation.J Hepatol 2001; 34:651-657

共引文献34

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部